Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 15:291:372-376.
doi: 10.1016/j.bbr.2015.05.036. Epub 2015 May 28.

Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking

Affiliations

Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking

Nii A Addy et al. Behav Brain Res. .

Abstract

The mesolimbic dopamine (DA) system is known to play a role in cue-mediated reward-seeking for natural rewards and drugs of abuse. Specifically, cholinergic and glutamatergic receptors in the ventral tegmental area (VTA) have been shown to regulate cue-induced drug-seeking. However, the potential role of these VTA receptors in regulating cue-induced reward seeking for natural rewards is unknown. Here, we examined whether blockade of VTA acetylcholine receptors (AChRs) and N-methyl-d-aspartate receptors (NMDARs) would alter cue-induced sucrose seeking in male Sprague-Dawley rats. Subjects underwent 10 days of sucrose self-administration training (fixed ratio 1 schedule) followed by 7 days of forced abstinence. On withdrawal day 7, rats received bilateral VTA infusion of vehicle, the muscarinic AChR antagonist scopolamine (2.4 or 24 μg/side), the nicotinic AChR antagonist mecamylamine (3 or 30 μg/side), or the NMDAR antagonist AP-5 (0.1 or 1 μg/side) immediately prior to examination of cue-induced sucrose-seeking. Scopolamine infusion led to robust attenuation, but did not completely block, sucrose-seeking behavior. In contrast, VTA administration of mecamylamine or AP-5 did not alter cue-induced sucrose-seeking. Together, the data suggest that VTA muscarinic AChRs, but not nicotinic AChRs nor NMDARs, facilitate the ability of food-associated cues to drive seeking behavior for a food reward.

Keywords: Mecamylamine; Mesolimbic dopamine system; NMDA receptor; Reward-seeking behavior; Scopolamine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A) Experimental timeline. B) Representative VTA cannula placements. C) Acquisition of sucrose-self administration behavior (FR 1) over 10 days (main effect of lever and training day, p < 0.0001; lever x day interaction, p < 0.0001).
Fig. 2
Fig. 2
Examination of cue-induced sucrose-seeking during VTA infusion of cholinergic receptor or NMDA receptor antagonists. Scopolamine infusion attenuated cue-induced sucrose-seeking (N = 23) A) over a 1 hr period (main effect of treatment p < 0.0005, main effect of lever p < 0.0001, treatment x lever interaction p < 0.01) and B) at specific 5 min bins. In contrast, mecamylamine infusion did not alter sucrose-seeking (N = 22) C) over a 1 hr session or D) at any of the 5 min bins. AP-5 infusion also did not alter sucrose-seeking (N= 24) E) during a 1 hr session or F) at any 5 min bins.

References

    1. Grimm JW, Harkness JH, Ratliff C, Barnes J, North K, Collins S. Effects of systemic or nucleus accumbens-directed dopamine D1 receptor antagonism on sucrose seeking in rats. Psychopharmacology (Berl) 2011;216:219–33. - PMC - PubMed
    1. Rohsenow DJ, Niaura RS, Childress AR, Abrams DB, Monti PM. Cue reactivity in addictive behaviors: theoretical and treatment implications. Int J Addict. 1990;25:957–93. - PubMed
    1. See RE. Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol. 2005;526:140–6. - PubMed
    1. Lof E, Olausson P, deBejczy A, Stomberg R, McIntosh JM, Taylor JR, et al. Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. Psychopharmacology (Berl) 2007;195:333–43. - PubMed
    1. Shaham Y, Hope BT. The role of neuroadaptations in relapse to drug seeking. Nat Neurosci. 2005;8:1437–9. - PubMed

Publication types

MeSH terms